CRSP: CRISPR Therapeutics AG Stock

by  •  • Comments Off on CRSP: CRISPR Therapeutics AG Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 3,190.17
Enterprise Value ($M) 2,954.99
Book Value ($M) 1,829.16
Book Value / Share 21.18
Price / Book 1.74
NCAV ($M) 1,530.67
NCAV / Share 17.72
Price / NCAV 2.08

Profitability (mra)
Return on Invested Capital (ROIC) -0.19
Return on Assets (ROA) -0.16
Return on Equity (ROE) -0.19

Liquidity (mrq)
Quick Ratio 15.64
Current Ratio 15.64

Balance Sheet (mrq) ($M)
Current Assets 1,867.61
Assets 2,166.10
Liabilities 336.94
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 37.31
Operating Income -466.57
Net Income -366.25
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -142.77
Cash from Investing -280.48
Cash from Financing 331.98

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-14 13G/A ARK Investment Management LLC 11.85 13.29
05-13 13G/A Capital International Investors 7.40 -22.98

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-02 681,639 2,140,053 31.85
2025-05-30 544,586 1,773,171 30.71
2025-05-29 952,423 2,547,187 37.39
2025-05-28 504,905 1,447,811 34.87

(click for more detail)

Similar Companies
CLYM – Climb Bio, Inc. CRMD – CorMedix Inc.
CRON – Cronos Group Inc. CRVS – Corvus Pharmaceuticals, Inc.
CURR – CURRENC Group Inc.


Financial data and stock pages provided by
Fintel.io